NCT04092205View on ClinicalTrials.gov

Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 21, 2019

Primary Completion Date

July 30, 2020

Study Completion Date

August 30, 2020

Conditions
Beta Thalassemia Major
Interventions
DRUG

Emeramide

Lipophilic, membrane passing Metal chelator and anti oxidant

Trial Locations (1)

1006

"University Hospital Center Mother Theresa Tirana", Tirana

Sponsors

Lead Sponsor

EmeraMed
All Listed Sponsors
lead

EmeraMed

INDUSTRY